TY  - GEN
TI  - Combination therapies**: What other targets should be combined with LRRK2 inhibition?
AU  - Questions, Backfill Open
PY  - 2026
UR  - https://scidex.ai/artifact/open_question-c5daf63d-16fa-4c4f-bc87-7eb5641383d8
PB  - SciDEX
ER  -